This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Smithkline Beecham Corporation. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Oliver Lars Rausch: Innovator in Neuropathic Treatment
Introduction
Oliver Lars Rausch is a notable inventor based in London, GB. He has made significant contributions to the field of medical science, particularly in the treatment of neuropathies and neurodegenerative conditions. His innovative work has the potential to impact the lives of many individuals suffering from chronic pain and related disorders.
Latest Patents
Rausch holds a patent for the use of KIAA0551 polypeptides and polynucleotides. This patent focuses on the design of protocols for treating neuropathies, neuropathic pain, inflammatory and chronic pain, as well as neurodegenerative conditions such as Motor Neuron Disease, Parkinson's Disease, Alzheimer's Disease, and other dementias. Additionally, it addresses ischaemic damage in neuronal and cardiac tissues caused by disease or infectious agents. The patent also discloses methods for producing these polypeptides through recombinant techniques.
Career Highlights
Oliver Lars Rausch is associated with SmithKline Beecham Corporation, where he continues to advance his research and development efforts. His work is characterized by a commitment to improving therapeutic options for patients with complex medical conditions.
Collaborations
Rausch collaborates with esteemed colleagues, including Sharon Bingham and Patrick Case. Their combined expertise enhances the research and development processes within their projects.
Conclusion
Oliver Lars Rausch is a pioneering inventor whose work in the field of neuropathic treatment holds great promise for future medical advancements. His contributions are vital in the ongoing quest to alleviate suffering from chronic and neurodegenerative conditions.